CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 100 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 100 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | -97.8% | 100 | -90.0% | 0.00% | -100.0% |
| Q3 2015 | $92,000 | +4.5% | 1,000 | 0.0% | 0.02% | +18.8% |
| Q2 2015 | $88,000 | +18.9% | 1,000 | 0.0% | 0.02% | +14.3% |
| Q1 2015 | $74,000 | +32.1% | 1,000 | 0.0% | 0.01% | +27.3% |
| Q4 2014 | $56,000 | +24.4% | 1,000 | 0.0% | 0.01% | +22.2% |
| Q3 2014 | $45,000 | +9.8% | 1,000 | 0.0% | 0.01% | +12.5% |
| Q2 2014 | $41,000 | -40.6% | 1,000 | 0.0% | 0.01% | -42.9% |
| Q1 2014 | $69,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |